Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$263M
1 round on record
Latest round
$263M
Venture round · Aug 2026 · 1 mo ago
Team
501-1000
employees, estimated range
Hiring now
1
open roles
Backers
1
ARCH Venture Partners
The money's age
Fresh money
1 months since the last round · hiring slowed
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2026 | $263M | — | streetinsider.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation…

We transform somatic genomics insights into potentially breakthrough medicines. Learn more at Quotient-Tx.com

Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of…

Soricimed Biopharma is a clinical stage drug development company dedicated to novel trageted treatments for cancer.

Frontier Medicines is boldly advancing science to defeat disease by pioneering innovations in precision-based medicines to target…

Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that…
News
LifeMine Therapeutics announced a $263M raise today to help accelerate the development of its novel calcineurin activation inhibitor that aims to radically change the profile of organ transplants
The post LifeMine Therapeutics announced a $263M raise today to help accelerate the development of its novel calcineurin activation inhibitor that aims to radically change the profile of organ transplants appeared first on LifeMine.
Read more
Report
Greg Verdine's LifeMine raises $263M for safer immunosuppressant
The post Greg Verdine's LifeMine raises $263M for safer immunosuppressant appeared first on LifeMine.
Read more
Report
A scientist-turned-biotech executive is notching some wins, and enjoying it
The post A scientist-turned-biotech executive is notching some wins, and enjoying it appeared first on LifeMine.
Read more
Report
Scientist-turned-biotech executive Greg Verdine is notching some wins, and enjoying it - The Boston Globe
Read more
Report
LifeMine Therapeutics Raises $263 Million To Advance LIFE-001 For Organ Transplantation
LifeMine Therapeutics has secured $263 million in financing to accelerate the clinical development of LIFE-001 and advance its broader pipeline of transplantation and immunology therapies. The financing includes an oversubscribed $188 million Series E rou
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~9 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
100% ▲
Offices
Where the company hires and what each office is for
Cities
4
Hiring now
1
Countries
2
Busiest office
Watertown
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Cambridge
United States
HQ
Watertown
United States
Regional office
Watertown, MA
1 open roles 1 posted in 90 days 500-1000 est. staff
hires for Early Careers
Basel
Switzerland
Regional office
Basel, CH
Gloucester
United States
Regional office
Gloucester, MA
Financials
Total raised
$263M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount |
|---|---|---|
| Venture - Series Unknown | 2026 | $263M |

ARCH Venture Partners